Vita Life Sciences (ASX:VLS) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

VLS 주식 개요

비타 라이프 사이언스는 호주, 싱가포르, 말레이시아, 태국, 베트남, 인도네시아, 중국에서 비타민과 보충제를 제조, 포장, 유통, 판매하는 헬스케어 회사입니다.

VLS 기본 분석
눈송이 점수
가치 평가	3/6
미래 성장	0/6
과거 실적	6/6
재무 상태	6/6
배당금	4/6

보상

공정 가치 추정치보다 낮은 2.7% 에서 거래

지난 1년간 수익이 28.2% 증가했습니다.

위험 분석

의미 있는 시가총액이 없습니다. ( A$133M )

불안정한 배당 실적

지난 3개월간 상당한 내부자 매도

Vita Life Sciences Limited 경쟁사

Vitura Health

ASX:VIT

AU$53.0m

ECS Botanics Holdings

ASX:ECS

AU$23.2m

EZZ Life Science Holdings

ASX:EZZ

AU$81.5m

Cryosite

ASX:CTE

AU$61.0m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Vita Life Sciences
과거 주가
현재 주가	AU$2.20
52주 최고치	AU$2.50
52주 최저치	AU$1.42
베타	0.44
11개월 변경	-2.22%
3개월 변경 사항	-9.84%
1년 변경 사항	40.58%
33년 변화	98.20%
5년 변화	203.45%
IPO 이후 변화	1,194.12%

최근 뉴스 및 업데이트

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14

Recent updates

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Mar 22

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Mar 14

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Dec 20

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

Aug 24

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

May 14

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Mar 18

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 17

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Jan 20

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

Dec 22

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Nov 19

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

Jul 14

주주 수익률

	VLS	AU Pharmaceuticals	AU 마켓
7D	-4.8%	1.3%	0.2%
1Y	40.6%	64.6%	7.5%

수익률 대 산업: VLS 지난 1년 동안 64.4 %를 반환한 Australian Pharmaceuticals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: VLS 지난 1년 동안 6.7 %를 반환한 Australian 시장을 초과했습니다.

가격 변동성

Is VLS's price volatile compared to industry and market?
VLS volatility
VLS Average Weekly Movement	6.1%
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	8.3%
10% most volatile stocks in AU Market	16.7%
10% least volatile stocks in AU Market	3.3%

안정적인 주가: VLS 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: VLS 의 주간 변동성( 6% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1947	n/a	Andrew O'Keefe	vitalifesciences.com

비타 라이프 사이언스는 호주, 싱가포르, 말레이시아, 태국, 베트남, 인도네시아, 중국에서 비타민과 보충제를 제조, 포장, 유통, 판매하는 헬스케어 회사입니다. 또한 다양한 미네랄, 허브, 슈퍼푸드도 제공합니다. 또한 신경계, 영양, 비뇨기 건강, 체중 관리, 면역, 피부, 모발, 손톱, 간 및 소화, 불임, 임신 및 산후, 혈당 관리, 심혈관 건강, 통증 및 염증, 남성, 여성 및 어린이 건강, 항산화제, 뼈, 관절, 근육, 눈 건강 등의 치료 영역에 대한 제품도 제공합니다.

Vita Life Sciences Limited 기본 사항 요약

Vita Life Sciences 의 수익과 매출은 시가총액과 어떻게 비교하나요?
VLS 기본 통계
시가총액	AU$124.44m
수익(TTM)	AU$9.08m
수익(TTM)	AU$74.16m

13.6x

P/E 비율

1.7x

P/S 비율

VLS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
VLS 손익 계산서(TTM)
수익	AU$74.16m
수익 비용	AU$31.05m
총 이익	AU$43.12m
기타 비용	AU$34.04m
수익	AU$9.08m

최근 보고된 수익

Dec 31, 2023

다음 수익 날짜

n/a

주당 순이익(EPS)	0.16
총 마진	58.14%
순이익 마진	12.24%
부채/자본 비율	0%

VLS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

4.1%

현재 배당 수익률

53%

지급 비율

VLS 주식 개요

보상

위험 분석

Vita Life Sciences Limited 경쟁사

ASX:VIT

AU$53.0m

ASX:ECS

AU$23.2m

ASX:EZZ

AU$81.5m

ASX:CTE

AU$61.0m

가격 내역 및 성능

최근 뉴스 및 업데이트

Non-Executive Chairman recently sold AU$654k worth of stock

New minor risk - Insider selling

MD & Director recently sold AU$1.9m worth of stock

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Upcoming dividend of AU$0.06 per share

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Recent updates

Non-Executive Chairman recently sold AU$654k worth of stock

New minor risk - Insider selling

MD & Director recently sold AU$1.9m worth of stock

Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Upcoming dividend of AU$0.06 per share

Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06

Vita Life Sciences Limited, Annual General Meeting, May 15, 2024

Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year

Final dividend increased to AU$0.06

Full year 2023 earnings released: EPS: AU$0.17 (vs AU$0.13 in FY 2022)

New minor risk - Insider selling

Vita Life Sciences Limited Provides Earnings Guidance for the Full Year Ending December 31, 2023

Upcoming dividend of AU$0.03 per share at 3.7% yield

First half 2023 earnings released: EPS: AU$0.074 (vs AU$0.069 in 1H 2022)

Vita Life Sciences Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, 6 October 2023

Vita Life Sciences Limited Appoints Peter Osborne as an Independent Non-Executive Director

Investor sentiment improves as stock rises 15%

Upcoming dividend of AU$0.033 per share at 3.9% yield

Full year 2022 earnings released: EPS: AU$0.13 (vs AU$0.16 in FY 2021)

No independent directors

A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)

Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022

No independent directors

Vita Life Sciences Limited Announces Board Changes, Effective 30 September 2022

Upcoming dividend of AU$0.028 per share

Vita Life Sciences Limited Declares Fully Franked Interim Dividend for the Six Months Ended June 30, 2022, Payable on 7 October 2022

First half 2022 earnings released: EPS: AU$0.069 (vs AU$0.07 in 1H 2021)

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2022

Non-Executive Chairman exercised options to buy AU$433k worth of stock.

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Upcoming dividend of AU$0.03 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Vita Life Sciences Limited Announces Dividend for Six Months Ended December 31, 2021, Payable on April 7, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of AU$0.028 per share

Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?

First half 2021 earnings released: EPS AU$0.07 (vs AU$0.058 in 1H 2020)

Independent Non-Executive Director Jonathan Tooth has left the company

Investor sentiment improved over the past week

Vita Life Sciences Limited Provides Earnings Guidance for the Half Year Ending June 30, 2021

If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late

Full year 2020 earnings released: EPS AU$0.12 (vs AU$0.057 in FY 2019)

Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?

Investor sentiment improved over the past week

Upcoming Dividend of AU$0.028 Per Share

Full year 2020 earnings released: EPS AU$0.12 (vs AU$0.057 in FY 2019)

Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?

Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?

Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching

New 90-day high: AU$1.00

Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Upcoming Dividend of AU$0.015 Per Share

New 90-day high - AU$0.95

First half earnings released

New 90-day high - AU$0.70

Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares

주주 수익률